Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Mukai

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Scientific Reports|March 25, 2021
Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathyHidetaka Matsumoto, Junki Hoshino, Ryo Mukai, et al.
Eye & Contact Lens|September 24, 2025
Temporal Changes in Tear Film Stability With Four Dry Eye Eyedrops in Healthy SubjectsManabu Suzutani, Hiroki Maehara, Shizuka Koh, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 24, 2023
Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathyRyo Mukai, Kanako Itagaki, Jyunichiro Honjyo, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 27, 2010
Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapyRyo Mukai, Shoji Kishi, Taku Sato, et al.
Scientific Reports|May 17, 2022
One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularizationHidetaka Matsumoto, Junki Hoshino, Ryo Mukai, et al.
Japanese Journal of Ophthalmology|May 30, 2026
Ocular microvascular alterations in patients with heart failure with preserved ejection fractionYoichiro Shinohara, Masaru Obokata, Ryo Mukai, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 14, 2022
Intravitreal Aflibercept versus Brolucizumab for Treatment-Naive Neovascular Age-Related Macular Degeneration with Type 1 Macular Neovascularization: Comparison of Short-Term OutcomesJunki Hoshino, Hidetaka Matsumoto, Ryo Mukai, et al.
Retina (Philadelphia, Pa.)|June 15, 2007
Tomographic features of branching vascular networks in polypoidal choroidal vasculopathyTaku Sato, Shoji Kishi, Goro Watanabe, et al.
International Medical Case Reports Journal|December 11, 2019
A Case Of Ipilimumab-Induced Unusual Serous Retinal Detachment In Bilateral EyesTomoko Miyakubo, Ryo Mukai, Kosuke Nakamura, et al.
Japanese Journal of Ophthalmology|February 5, 2020
One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesionsHidetaka Matsumoto, Ryo Mukai, Yuka Kikuchi, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Scientific Reports|March 25, 2021
Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathyHidetaka Matsumoto, Junki Hoshino, Ryo Mukai, et al.
Eye & Contact Lens|September 24, 2025
Temporal Changes in Tear Film Stability With Four Dry Eye Eyedrops in Healthy SubjectsManabu Suzutani, Hiroki Maehara, Shizuka Koh, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|August 24, 2023
Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathyRyo Mukai, Kanako Itagaki, Jyunichiro Honjyo, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|February 27, 2010
Protective effect of intravitreal bevacizumab and sub-tenon triamcinolone acetonide against occlusion of choriocapillaris induced by photodynamic therapyRyo Mukai, Shoji Kishi, Taku Sato, et al.
Scientific Reports|May 17, 2022
One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularizationHidetaka Matsumoto, Junki Hoshino, Ryo Mukai, et al.
Japanese Journal of Ophthalmology|May 30, 2026
Ocular microvascular alterations in patients with heart failure with preserved ejection fractionYoichiro Shinohara, Masaru Obokata, Ryo Mukai, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|July 14, 2022
Intravitreal Aflibercept versus Brolucizumab for Treatment-Naive Neovascular Age-Related Macular Degeneration with Type 1 Macular Neovascularization: Comparison of Short-Term OutcomesJunki Hoshino, Hidetaka Matsumoto, Ryo Mukai, et al.
Retina (Philadelphia, Pa.)|June 15, 2007
Tomographic features of branching vascular networks in polypoidal choroidal vasculopathyTaku Sato, Shoji Kishi, Goro Watanabe, et al.
International Medical Case Reports Journal|December 11, 2019
A Case Of Ipilimumab-Induced Unusual Serous Retinal Detachment In Bilateral EyesTomoko Miyakubo, Ryo Mukai, Kosuke Nakamura, et al.
Japanese Journal of Ophthalmology|February 5, 2020
One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesionsHidetaka Matsumoto, Ryo Mukai, Yuka Kikuchi, et al.
Pageof 8